ALK-B.CO Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (19 Apr 2024 @ 05:16):

Stats
Today's Volume	20 868.00
Average Volume	294 611
Market Cap	27.85B
EPS	DKK0 ( 2024-02-07 )
Next earnings date	( DKK0 ) 2024-05-02
Last Dividend	DKK0 ( N/A )
Next Dividend	DKK0 ( N/A )
P/E	56.59
ATR14	DKK0.127 (0.10%)

Volume Correlation

Long: 0.40 (neutral)

Short: 0.74 (moderate)

Signal:(70.514) Neutral

ALK-Abelló A/S Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

ALK-Abelló A/S Correlation - Currency/Commodity

0.54
( weak )

-0.10
( neutral )

0.31
( neutral )

0.72
( moderate )

0.20
( neutral )

-0.53
( weak negative )

ALK-Abelló A/S Financials

Annual	2023
Revenue:	DKK4.82B
Gross Profit:	DKK3.04B (62.91 %)
EPS:	DKK2.20

Q4	2023
Revenue:	DKK1.35B
Gross Profit:	DKK844.00M (62.75 %)
EPS:	DKK0.630

Q3	2023
Revenue:	DKK1.11B
Gross Profit:	DKK685.00M (61.71 %)
EPS:	DKK0.530

Q2	2023
Revenue:	DKK1.14B
Gross Profit:	DKK707.00M (62.29 %)
EPS:	DKK0.300

Financial Reports:

No articles found.

ALK-Abelló A/S

ALK-Abelló A/S operates as an allergy solutions company in Europe, North America, and internationally. It product portfolio include GRAZAX/GRASTEK, RAGWITEK/RAGWIZAX, ACARIZAX/ODACTRA, MITICURE, CEDACURE, and ITULAZAX for treatment of allergic rhinitis and allergic asthma. The company offers allergy immunotherapy products in the form of injections, sublingual drops, and tablets for the treatment of various allergies, including grass, ragweed, house dust mite, Japanese cedar, tree, and food. It also provides consumer healthcare solution, which include Digital eco-system, a platform which connect and engages with allergy sufferers much earlier in the disease journey through tools and e-commerce offerings that supports, guidance and relief, and smoothing the path to allergy immunotherapy treatment. In addition, the company offers diagnostic allergy solutions through testing by skin prick test or blood test; and emergency treatment, such as intramuscular injection of adrenaline for the treatment of acute life-threatening allergic reactions including Anaphylaxis. ALK-Abelló A/S was founded in 1923 and is headquartered in Hørsholm, Denmark.